Rheumatic disorders associated with hepatitis C

Bailliere's Best Practice and Research in Clinical Rheumatology

Volumn 14, Issue 3, 2000, Pages 535-557

  Lövy, Michael Robert ^a   Starkebaum, Gordon ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Arthritis; Dermatological manifestations; Diagnostic tests; Glomerulonephritis; Hepatitis C; Liver disease; Mixed cryoglobulinaemia; Neurological manifestations; Non Hodgkin's lymphoma; Rheumatic disorders; Serological abnormalities; Sjogren's syndrome; Skin disorder

Indexed keywords

ALPHA INTERFERON; AMINOTRANSFERASE; ANTIRHEUMATIC AGENT; AUTOANTIBODY; AUTOANTIGEN; CHLOROQUINE; CORTICOSTEROID; CYCLOSPORIN; ETANERCEPT; HEPATITIS A HEPATITIS B VACCINE; HYDROXYCHLOROQUINE; IBUPROFEN; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PREDNISONE; RIBAVIRIN; TACROLIMUS; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; URSODEOXYCHOLIC ACID;

AUTOIMMUNE DISEASE; CRYOGLOBULINEMIA; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DOSE RESPONSE; GLOMERULONEPHRITIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER DISEASE; LIVER TOXICITY; NEUROLOGIC DISEASE; NONHODGKIN LYMPHOMA; NONHUMAN; PHLEBOTOMY; PRIORITY JOURNAL; REVIEW; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; SKIN DISEASE; VIRUS TRANSMISSION;

EID: 0033807494     PISSN: 15216942     EISSN: None     Source Type: Journal    
DOI: 10.1053/berh.2000.0092     Document Type: Article

References (99)

1. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome
2. Global surveillance and control of hepatitis C
3. The hepatitis C virus: Overview
4. Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: Quasispecies nature of HCV genome distribution
5. Specific detection of hepatitis C virus minus strand RNA in hematopoietic cells
6. A role for hepatitis C virus infection in type II cryoglobulinemia
7. Hepatitis C: The clinical spectrum of disease
8. Does the healthy hepatitis C virus carrier state really exist? An analysis using polymerase chain reaction
9. Significance of repeatedly normal aminotransferase activities in HCV-infected patients
10. Sexual and perinatal transmission of hepatitis C
11. Risk factors associated with chronic hepatitis C virus infection: Limited frequency of an unidentified source of transmission
12. Diagnostic tests for hepatitis C
13. Detection of antibodies against hepatitis C virus in saliva: A marker of viral replication
14. Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment Virus C
15. High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C
16. Serological and clinical markers of autoimmune disease in HCV-infected subjects with different disease conditions
17. Hepatitis C virus and Hashimoto's thyroiditis
18. Anticardiolipin, anti-beta2-glycoprotein I, and antinucleosome antibodies in hepatitis C virus infection and mixed cryolobulinemia
19. Prevalence of hepatitis C virus infection in patients with antiphospholipid syndrome
20. Immunological disorders in C virus chronic active hepatitis: A prospective case-control study
21. Viruses and thrombotic microangiopathy
22. High mobility group (HMG) non-histone chromosomal proteins HMG1 and HMG2 are significant target antigens of perinuclear anti-neutrophil cytoplasmic antibodies in autoimmune hepatitis
23. Viral induction of autoimmunity: Mechanisms and examples in hepatology
24. Prevalence and significance of thyroid autoantibodies in patients with chronic hepatitis C virus infection: A prospective controlled study
25. Autoimmune thrombocytopenia associated with hepatitis C virus infection
26. Persistence of hepatitis C virus in a human megakaryoblastic leukemia cell line
27. Biologic and clinical significance of cryoglobulins. A report of 86 cases
28. Localization of hepatitis C virus in cutaneous vasculitic lesions in patients with type II cryoglobulinemia
29. Membranous glomerulonephritis in association with hepatitis C virus infection
30. Focal segmental glomerular sclerosis among patients infected with hepatitis C virus
31. Renal manifestations of hepatitis C infection
32. Peripheral neuropathy in mixed cryoglobulinemia: Clinical and electrophysiologic investigations
33. Hepatitis C virus associated cryoglobulinemic neuropathy successfully treated with plasma exchange
34. Neurological manifestations of chronic hepatitis C
35. Isolated CNS vasculitis associated with hepatitis C infection
36. Hepatitis C virus RNA detection in oral lichen planus tissue
37. Oral lichen planus and HCV infection: A clinical evaluation of 263 cases
38. Hepatitis C virus and porphyria cutanea tarda: Evidence of a strong association
39. Porphyria cutanea tarda and hepatitis C virus: A case-control study and meta-analysis of the literature
40. Hepatitis C virus infection in cutaneous polyarteritis nodosa: A retrospective study of 16 cases
41. Cutaneous periarteritis nodosa: A clinicopathological study of 79 cases
42. Necrolytic acral erythema: A cutaneous marker of viral hepatitis C
43. Sjogren's syndrome and hepatitis C virus
44. Extrahepatic manifestations of chronic hepatitis C infection and the interrelationship between primary Sjogren's syndrome and hepatitis C in Swedish patients
45. Absence of hepatitis C viral infection among patients with primary Sjogren's syndrome
46. Cryoglobulinemia in primary Sjogren's syndrome: Prevalence and clinical characteristics in a series of 115 patients
47. Lymphocytic sialadenitis of Sjogren's syndrome associated with chronic hepatitis C virus liver disease
48. Sicca syndrome associated with hepatitis C virus infection
49. Chronic lymphocytic sialoadenitis in HCV-related chronic liver disease: Comparison of Sjogren's syndrome
50. Immunohistochemistry of minor salivary gland biopsy specimens from patients with Sjogren's syndrome with and without hepatitis C virus infection
51. Hepatitis C virus propagates in salivary glands
52. Hepatitis C virus infection in 'primary' Sjogren's syndrome: Prevalence and clinical significance in a series of 90 patients
53. Development of rheumatoid arthritis after hepatitis C virus infection
54. Development of rheumatoid arthritis after chronic hepatitis caused by hepatitis C virus infection
55. A case of hepatitis C virus (HCV)-associated arthritis. Quantitative analysis of HCV RNA of the synovial fluid and the serum
56. Has hepatitis C virus a specific tropism for the synovial membrane?
57. Hepatitis C infection presenting with rheumatic manifestations: A mimic of rheumatoid arthritis
58. Hepatitis C viremia in chronic liver disease: Relationship to interferon-alpha or corticosteroid treatment
59. Long-term administration of cyclosporin A to HCV-antibody-positive patients with dermatologic diseases
60. Hepatitis C virus (HCV) specific immune responses in anti-HCV positive patients without hepatitis C viraemia
61. Ibuprofen-induced hepatotoxicity in patients with chronic hepatitis C: A case series
62. Soluble tumor necrosis factor receptors in chronic hepatitis C: A correlation with histological fibrosis and activity
63. Hepatitis C virus infection and clonal B-cell expansion
64. Hepatitis C virus infection, mixed cryoglobulinemia, and non-Hodgkin's lymphoma: An emerging picture
65. Prevalence of monoclonal gammopathies in patients with hepatitis C virus infection
66. Cross-idiotypic specificity among monoclonal IgM proteins with anti-globulin activity
67. Clonal B cell expansions in patients with essential mixed cryoglobulinaemia
68. Clonal B-cell expansions in peripheral blood of HCV-infected patients
69. Mixed cryoglobulinemia cross-reactive idiotypes: Implications for the relationship of MC to rheumatic and lymphoproliferative diseases
70. Somatic hypermutation, clonal diversity, and preferential expression of the VH 51pl/VL kv325 immunoglobulin gene combination in hepatitis C virus-associated immunocytomas
71. Hepatitis C virus-related lymphomas
72. HCV and HGV in B-cell non-Hodgkins lymphoma
73. Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma
74. In vivo tropism of hepatitis C virus genomic sequences in hematopoietic cells: Influence of viral load, viral genotype, and cell phenotype
75. Hepatitis C virus persistence in human hematopoietic cells injected into SCID mice
76. Hepatitis C virus infection involves CD34(+) hematopoietic progenitor cells in hepatitis C virus chronic carriers
77. Suppression of apoptotic cell death by hepatitis C virus core protein
78. Hepatitis C virus core protein represses p21WAFI/CipI/SidI promoter activity
79. Polyarteritis nodosa and hepatitis C virus infection
80. Frequency and significance of antibodies to hepatitis C virus in polyarteritis nodosa
81. Hepatitis C infection presenting with rheumatic manifestations
82. Musculoskeletal pain and fatigue are associated with chronic hepatitis C: A report of 239 hepatology clinic patients
83. Fibromyalgia-associated hepatitis C virus infection
84. Fibromyalgia in hepatitis C virus infection. Another infectious disease relationship
85. Interstitial lung fibrosis and rheumatic disorders in patients with hepatitis C virus infection
86. Interferon alpha for ocular Behcet's disease
87. Rheumatic manifestations of hepatitis B virus infection
88. Chronic hepatitis
89. Autoimmune hepatitis versus viral hepatitis C
90. Effect of ursodeoxycholic acid on autoimmune-associated chronic hepatitis C
91. Antinuclear autoantibodies specific for lamins. Characterization and clinical significance
92. Risk of hepatitis A superinfection in patients with underlying liver disease
93. Chronic hepatitis C infection. A disease ideally suited to management in the primary care setting
94. Low-titre auto-antibodies predict autoimmune disease during interferon-alpha treatment of chronic hepatitis C
95. Side effects of alpha interferon in chronic hepatitis C
96. A survey of adverse events in 11 241 patients with chronic viral hepatitis treated with alfa interferon
97. Combination therapy with interferon plus ribavirin for the initial treatment of chronic hepatitis C
98. Treatment of polyarteritis nodosa and microscopic polyangiitis
99. Therapy of hepatitis C: Patients with normal aminotransferase levels